Results 151 to 160 of about 216,693 (188)
Some of the next articles are maybe not open access.

Complement inhibition in C3 glomerulopathy

Seminars in Immunology, 2016
C3 glomerulopathy (C3G) describes a spectrum of glomerular diseases defined by shared renal biopsy pathology: a predominance of C3 deposition on immunofluorescence with electron microscopy permitting disease sub-classification. Complement dysregulation underlies the observed pathology, a causal relationship that is supported by well described studies ...
Carla M Nester, Richard J Smith
exaly   +3 more sources

C3 Glomerulopathy

Pediatric Nephrology, 2016
Recent advances in our understanding of the disease pathology of membranoproliferative glomerulonephritis has resulted in its re-classification as complement C3 glomerulopathy (C3G) and immune complex-mediated glomerulonephritis (IC-GN). The new consensus is based on its underlying pathomechanism, with a key pathogenetic role for the complement ...
Magdalena, Riedl   +2 more
openaire   +2 more sources

C3 Glomerulopathy

2013
C3 glomerulopathy is a recent disease classification comprising several rare types of glomerulonephritis, including dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). The most common histological feature in these diseases is the presence of glomerular deposition of C3 within the mesangium and along the glomerular basement membrane (GBM) in ...
Aude, Servais   +3 more
openaire   +2 more sources

Update on C3 Glomerulopathy

Advances in Kidney Disease and Health
C3 glomerulopathy (C3G) is a rare disorder marked by deposition of C3 in the glomerulus, resulting in damage to the glomerular filtration unit and presenting with features of the nephritic and nephrotic syndromes. Fundamentally, C3G is caused by dysregulation of the alternative pathway of the complement cascade, either due to genetic variants or ...
Benjamin, Wooden   +2 more
openaire   +2 more sources

C3 Glomerulopathy: Pathogenesis and Treatment

Advances in Chronic Kidney Disease, 2020
C3 glomerulopathy (C3G) is a rare set of kidney diseases with 2 patterns: C3 glomerulonephritis (C3GN) and dense deposit disease. Pathogenesis of both diseases is due to complement dysregulation in the alternative pathway. Acquired or genetic alterations of the regulatory proteins of the complement pathway result in C3G.
Syeda Behjat, Ahmad, Andrew S, Bomback
openaire   +2 more sources

The role of complement in C3 glomerulopathy

Molecular Immunology, 2015
C3 glomerulopathy describes a spectrum of disorders with glomerular pathology associated with C3 cleavage product deposition and with defective complement action and regulation (Fakhouri et al., 2010; Sethi et al., 2012b). Kidney biopsies from these patients show glomerular accumulation or deposition of C3 cleavage fragments, but no or minor deposition
Peter F. Zipfel   +11 more
openaire   +2 more sources

[C3 glomerulopathy].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2015
C3 glomerulopathy includes C3 glomerulonephritis, Dense Deposit Disease, Factor H-Related Protein 5 (CFHR5) nephropathy and most atypical acute postinfectious glomerulonephritis. The characteristic of this nephropathy is C3 deposits without immunoglobulins. Light microscopy pattern can be mesangial proliferative or membrano-proliferative.
Sophie, Chauvet   +2 more
openaire   +3 more sources

Diagnosis and treatment of C3 glomerulopathy

Clinical Nephrology, 2013
The purpose of this review is to summarize our current understanding of the principal characteristics of C3 glomerulopathy as a framework for patient evaluation with the goal of setting the stage for a mechanistic approach to treatment. We also review published treatment experience and comment on future initiatives to devise treatment protocols for ...
Carla M, Nester, Richard J, Smith
openaire   +2 more sources

Histopathology of MPGN and C3 glomerulopathies

Nature Reviews Nephrology, 2014
'Membranoproliferative' describes glomerular injury characterized by capillary wall thickening and mesangial expansion owing to increased matrix deposition and hypercellularity. The presence of immune deposits is indicative of membranoproliferative glomerulonephritis (MPGN).
H Terence, Cook, Matthew C, Pickering
openaire   +2 more sources

Membranoproliferative Glomerulonephritis und C3‑Glomerulopathie

Der Internist, 2019
Based on an increasingly better pathophysiological understanding over the last 10 years, in 2010 a new classification of glomerulonephritis with dominant or codominant C3 deposits was introduced and the predominant subgoup was termed C3 glomerulopathy (C3G). In the current classification, immune complex mediated membranoproliferative glomerulonephritis
B, Hohenstein, K, Amann, J, Menne
openaire   +2 more sources

Home - About - Disclaimer - Privacy